Norman Payson - Oct 24, 2022 Form 4 Insider Report for Progyny, Inc. (PGNY)

Role
Director
Signature
/s/ Mark Livingston, Attorney-in-Fact
Stock symbol
PGNY
Transactions as of
Oct 24, 2022
Transactions value $
$0
Form type
4
Date filed
10/26/2022, 05:48 PM
Previous filing
Oct 14, 2022
Next filing
Oct 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGNY Common Stock Award $0 +3.48K +40.22% $0.00 12.1K Oct 24, 2022 Direct F1
holding PGNY Common Stock 122K Oct 24, 2022 See footnote F2
holding PGNY Common Stock 339K Oct 24, 2022 See footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PGNY Stock Option (Right to Buy) Award $0 +15.1K $0.00 15.1K Oct 24, 2022 Common Stock 15.1K $38.22 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs shall vest on May 23, 2023 subject to the Reporting Person continuing to provide service through such date.
F2 The reportable securities are directly held by EVO Eagle, LLC. The Reporting Person shares voting and dispositive power over the securities.
F3 The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust.
F4 The shares subject to the Option shall vest on May 23, 2023, subject to the Reporting Person continuing to provide service through such date.